OTHER GROUP COMPANIES
market

Bafna Pharma stock rallies 8%

The company has got the renewal certificate from Medicines and Healthcare products Regulatory Agency (MHRA), London.

June 10, 2015 11:38 IST | India Infoline News Service
Bafna Pharmaceuticals is trading on a gung-ho note on the BSE on successfully completing MHRA audit process.

According to a release issued to the BSE, the company has got the renewal certificate from Medicines and Healthcare products Regulatory Agency (MHRA), London.

The stock so far has soared 17.8 percent to a high at Rs. 29.40 and is now up 9.8 percent at Rs. 27.40.

The BSE counter has seen 6.1-times jump in volume with trades of around 98,000 shares, as against two-week daily average volume of 16,000 shares.

Meanwhile, the Sensex has jumped 245 points at 26,726.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity